Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT

Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”

“…Reply to "Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients" Gabriel Jakobsson 1 , Henrik Andersson 2 , Michelle Chew 2 and Alexandru Schiopu 1,3,4,5* We would like to address the comments by Honoré et al [1] referring to our recently published paper "Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction" [2].…”